PubRank

Tomoyuki Hishida

Author PubWeight™ 56.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients. J Thorac Oncol 2014 1.97
2 Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. Chest 2011 1.76
3 The clinical outcome of non-small cell lung cancer patients with adjacent lobe invasion: the optimal classification according to the status of the interlobar pleura at the invasion point. Eur J Cardiothorac Surg 2012 1.69
4 Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 2008 1.59
5 Prognostic significance of a solid component in pulmonary adenocarcinoma. Ann Thorac Surg 2011 1.59
6 Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma. Ann Thorac Surg 2012 1.44
7 Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci 2009 1.15
8 Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2010 1.15
9 Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J Thorac Oncol 2010 1.12
10 Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 2013 1.12
11 Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol 2012 1.09
12 Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients. J Thorac Oncol 2010 1.03
13 Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? Lung Cancer 2010 1.01
14 Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment. J Thorac Oncol 2012 0.97
15 Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 2013 0.97
16 Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells. Lung Cancer 2006 0.97
17 Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol 2009 0.96
18 Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal? Jpn J Clin Oncol 2011 0.95
19 Risk factors of postoperative respiratory infections in lung cancer surgery. J Thorac Oncol 2007 0.95
20 The prognostic impact of cigarette smoking on patients with non-small cell lung cancer. J Thorac Oncol 2011 0.95
21 Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up. Chest 2010 0.95
22 Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients. J Thorac Oncol 2011 0.94
23 Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol 2010 0.93
24 Two lung adenocarcinomas in the same lobe: multiple primaries or intrapulmonary metastasis? Ann Thorac Cardiovasc Surg 2011 0.93
25 Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection. J Thorac Oncol 2015 0.93
26 Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype. Chest 2013 0.93
27 Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size. Lung Cancer 2012 0.90
28 Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma. Cancer Sci 2013 0.90
29 Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension. Chest 2010 0.90
30 Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer. Chest 2010 0.87
31 Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma. Cancer 2009 0.87
32 Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer. J Thorac Oncol 2010 0.87
33 Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens. Lung Cancer 2011 0.86
34 Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients. Thorax 2010 0.86
35 Identification of early t1b lung adenocarcinoma based on thin-section computed tomography findings. J Thorac Oncol 2013 0.86
36 Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma. Ann Surg Oncol 2012 0.85
37 The role of pulmonary resection in tumors metastatic from head and neck carcinomas. Jpn J Clin Oncol 2010 0.85
38 Multiple perivascular epithelioid cell tumors: clear cell tumor of the lung accompanied by angiomyolipoma of the liver. Ann Thorac Cardiovasc Surg 2013 0.84
39 Malignant granular cell tumor of the posterior mediastinum with dissemination. Asian Cardiovasc Thorac Ann 2012 0.84
40 Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases. Pathol Int 2011 0.83
41 Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung. J Cancer Res Clin Oncol 2013 0.83
42 Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients. Ann Surg 2014 0.82
43 Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-small-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection. J Thorac Oncol 2012 0.81
44 Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation. Hum Pathol 2013 0.81
45 Pulmonary metastasis from encapsulated cervical ectopic type a thymoma. Ann Thorac Surg 2012 0.81
46 Identification of intravascular tumor microenvironment features predicting the recurrence of pathological stage I lung adenocarcinoma. Cancer Sci 2013 0.79
47 Characteristic immunophenotype of solid subtype component in lung adenocarcinoma. Ann Surg Oncol 2012 0.79
48 Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma. J Thorac Oncol 2011 0.79
49 Tumor-size-based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma. Pathol Int 2014 0.79
50 Visceral pleural invasion classification in non-small cell lung cancer. J Thorac Oncol 2010 0.79
51 The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg 2009 0.78
52 Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung. Lung Cancer 2006 0.78
53 Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol 2012 0.78
54 Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma. Cancer Sci 2014 0.78
55 Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Cancer Sci 2012 0.78
56 The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma. Clin Lung Cancer 2013 0.78
57 Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment. J Cancer Res Clin Oncol 2014 0.78
58 Prognostic impact of node involvement pattern in pN1 non-small cell lung cancer patients. J Thorac Oncol 2010 0.78
59 Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma. Pathol Int 2010 0.76
60 Reply to Wang et al. Eur J Cardiothorac Surg 2012 0.75
61 The availability of pre- and intraoperative evaluation of a solitary pulmonary nodule in breast cancer patients. Ann Thorac Cardiovasc Surg 2014 0.75
62 Tumor invasion of extralobar soft tissue beyond the hilar region does not affect the prognosis of surgically resected lung cancer patients. J Thorac Oncol 2010 0.75
63 Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. Jpn J Clin Oncol 2016 0.75
64 Malignant pleural mesothelioma with osteosarcomatous differentiation: characteristic bone scintigraphy findings associated with enhanced tumorous osteogenesis. Eur J Cardiothorac Surg 2010 0.75
65 Late pulmonary metastasis of a rectal cancer resected 20 years after low anterior resection. Ann Thorac Cardiovasc Surg 2008 0.75
66 Complete left-sided pericardial defect in a lung cancer patient undergoing pneumonectomy without closure of the defect. Ann Thorac Cardiovasc Surg 2011 0.75
67 Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. Jpn J Clin Oncol 2017 0.75
68 The recurrence of malignant pleural mesothelioma 14 years after extrapleural pneumonectomy: possible histological transformation. Pathol Int 2012 0.75
69 Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients. J Thorac Oncol 2010 0.75
70 Effectiveness of Bone Suppression Imaging in the Detection of Lung Nodules on Chest Radiographs: Relevance to Anatomic Location and Observer's Experience. J Thorac Imaging 2017 0.75